Tafenoquine for vivax malaria elimination and Hidden malaria transmission among Myanmar migrants in Thailand
Dr Aung Pyae Phuo, MORU Tropical Health Network
Dr Pyae Linn Aung, Mahidol Vivax Research Unit
Modelling SP resistance through dhfr and dhps haplotypes and Spatio-temporal agent-based modelling of Malaria
Dr Imke Botha, The University of Melbourne
Md Nurul Anwar, The University of Melbourne
Malaria drug efficacy, mysterious etiologies and hyperparasitaemia – studies of African malaria in UK travellers and Delayed treatment of malaria in Africa, then and now: Challenges and implications for burden reduction targets
Professor Colin Sutherland, London School of Hygiene and Tropical Medicine
Jailos Lubinda, The Kids Research Institute
Utilising serological markers to predict recurrent plasmodium vivax infections in the ‘Patients Receiving Primaquine Radical Cure for Plasmodium falciparum (PRIMA) study
Maulina Hafidzah, University of Melbourne
Genetic surveillance of P. falciparum populations following treatment policy revisions in the Greater Mekong Subregion and Genetic Surveillance of P. vivax in the Greater Mekong Subregion
Varanya Wasakul and Ethan Booth, MORU Tropical Health Network
